Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.645 USD | +2.67% | +12.71% | +32.31% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.31% | 534M | |
-2.47% | 88.14B | |
+3.29% | 40.44B | |
-15.84% | 32.24B | |
+51.96% | 24.39B | |
-14.57% | 15.59B | |
-39.65% | 12.3B | |
-6.52% | 12.18B | |
-13.94% | 12.14B | |
+5.17% | 8.87B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Avid Bioservices : RBC Raises Price Target on Avid Bioservices to $27 From $21 After Fiscal Q4 Revenue Beat, Maintains Outperform Rating